NRAS and metastatic melanoma: Gerber et al. [95] used scRNA-seq to analyze transcription in cells from three different metastatic melanoma patients (BRAF/NRAS wild type, BRAF mutant/NRAS wild type, and BRAF wild type /NRAS mutant).